79 related articles for article (PubMed ID: 2090223)
1. [Allopurinol in the treatment of HIV-infected patients with visceral leishmaniasis].
Mora A; Borrell M; Galofré J; Grau JM
Enferm Infecc Microbiol Clin; 1990 Apr; 8(4):257-8. PubMed ID: 2090223
[No Abstract] [Full Text] [Related]
2. [Visceral leishmaniasis in patients with HIV infection. Our experience].
Terra L; Pellicanò S; Allò M
Minerva Med; 1996 Jun; 87(6):317-9. PubMed ID: 8700361
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of visceral leishmaniasis with fluconazole and allopurinol in a patient with renal failure.
Colakoglu M; Yaylali GF; Colakoglu NY; Yilmaz M
Scand J Infect Dis; 2006; 38(2):152-4. PubMed ID: 16449014
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of visceral leishmaniasis with fluconazole and allopurinol in a patient with renal failure.
Colakoglu M; Fidan Yaylali G; Yalcin Colakoglu N; Yilmaz M
Scand J Infect Dis; 2006; 38(3):208-10. PubMed ID: 16500783
[TBL] [Abstract][Full Text] [Related]
5. [Visceral leishmaniasis with benign course in a patient infected with human immunodeficiency virus].
Ribelles N; Casals A; Vallés J; Clotet B
Med Clin (Barc); 1989 May; 92(17):679. PubMed ID: 2747338
[No Abstract] [Full Text] [Related]
6. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
[TBL] [Abstract][Full Text] [Related]
7. Comment on: Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.
Collazos J
J Antimicrob Chemother; 2008 Feb; 61(2):466-7; author reply 467. PubMed ID: 18077312
[No Abstract] [Full Text] [Related]
8. [Visceral leishmaniasis in patients with HIV infection].
Ribera E; Cucurull E; Ocaña I; Vallespí T; Gasser I; Juste C
Enferm Infecc Microbiol Clin; 1995 Feb; 13(2):73-9. PubMed ID: 7711130
[TBL] [Abstract][Full Text] [Related]
9. The role of splenectomy in HIV-infected patients with relapsing visceral leishmaniasis.
Troya J; Casquero A; Muñiz G; Fernández-Guerrero ML; Górgolas M
Parasitology; 2007 May; 134(Pt 5):621-4. PubMed ID: 17156583
[TBL] [Abstract][Full Text] [Related]
10. [Visceral leishmaniasis as an opportunistic infection. Case report and literature review].
Moradpour D; Markwalder K; Greminger P; Lüthy R
Schweiz Rundsch Med Prax; 1990 Aug; 79(31-32):921-6. PubMed ID: 2203128
[TBL] [Abstract][Full Text] [Related]
11. Miltefosine for visceral leishmaniasis relapse treatment and secondary prophylaxis in HIV-infected patients.
Marques N; Sá R; Coelho F; Oliveira J; Saraiva Da Cunha J; Meliço-Silvestre A
Scand J Infect Dis; 2008; 40(6-7):523-6. PubMed ID: 18584541
[TBL] [Abstract][Full Text] [Related]
12. Visceral leishmaniasis and tuberculosis in patients with HIV co-infection.
Das VN; Pandey K; Kumar N; Hassan SM; Bimal S; Lal CS; Siddiqui NA; Bhattacharya SK
Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):18-21. PubMed ID: 16771207
[TBL] [Abstract][Full Text] [Related]
13. Clinical, haematological and parasitological response to treatment of visceral leishmaniasis in Kenya. A study of 64 patients.
Kager PA; Rees PH; Manguyu FM; Bhatt KM; Wellde BT; Hockmeyer WT; Lyerly WH
Trop Geogr Med; 1984 Mar; 36(1):21-35. PubMed ID: 6328709
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of visceral leishmaniasis in patients with antimonials: is there a maximal dose?].
Llorens Soriano P; Vicente Ull R; Paricio Blasco A; Cervera Juan A; Rubio Rodrigo MJ
An Med Interna; 1999 Nov; 16(11):602. PubMed ID: 10638007
[No Abstract] [Full Text] [Related]
15. [Visceral leishmaniasis with partial response to ketoconazole in a patient with positive antibodies to the human immunodeficiency virus].
Andreo JA; Vivancos F; Serrano P; Soriano J
Med Clin (Barc); 1991 Oct; 97(12):476-7. PubMed ID: 1753824
[No Abstract] [Full Text] [Related]
16. [Secondary amyloidosis with irreversible acute renal failure caused by visceral leishmaniasis in a patient with AIDS].
Navarro M; Bonet J; Bonal J; Romero R
Nefrologia; 2006; 26(6):745-6. PubMed ID: 17227255
[TBL] [Abstract][Full Text] [Related]
17. [Glucantime and allopurinol in the treatment of persistent infantile visceral leishmaniasis].
de la Cruz Amorós E; Lambruschini Ferri N; Rodríguez Miguélez JM; Torres Simón JM
An Esp Pediatr; 1988 Jul; 29(1):77-9. PubMed ID: 3190011
[No Abstract] [Full Text] [Related]
18. [Atypical presentation and fatal evolution of visceral leishmaniasis in a patient infected with HIV].
Muńiz Grijalvo O; Losada Vińau J; Rizo Valero A; Miranda Guisado ML
Rev Clin Esp; 1991 Jul; 189(3):151-2. PubMed ID: 1947393
[No Abstract] [Full Text] [Related]
19. Visceral leishmaniasis as a cause of anemia in HIV-infected patients.
Cascio A; Iaria C; Antinori S
Clin Infect Dis; 2004 Oct; 39(7):1088-9. PubMed ID: 15472874
[No Abstract] [Full Text] [Related]
20. Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine and paromomycin administration.
Manfredi R; Marinacci G; Calza L; Passarini B
Int J Antimicrob Agents; 2008 Jun; 31(6):590-2. PubMed ID: 18456464
[No Abstract] [Full Text] [Related]
[Next] [New Search]
